Skip to content

Frenaver: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Frenaver

BE 0461.238.364
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€9,694
2024 · €6,171+€3,523
Equity
€219,487
2024 · €209,793+€9,694
Cash
€5,909
2024 · €28,282-€22,373
Balance sheet total
€418,862
2024 · €430,047-€11,185

Largest movements

2024 to 2025
Assets
  • Cash -€22,373

    down €22,373 (-79.1%), from €28,282 to €5,909

    mainly Trade debts (-€23,757) and Deferred charges and accrued income (-€11,574)

  • Tangible fixed assets -€17,488

    down €17,488 (-30.5%), from €57,370 to €39,882

    of which Plant, machinery and equipment: -€13,203

  • Deferred charges and accrued income +€11,574

    up €11,574 (+17.3%), from €66,749 to €78,323

  • Receivables within one year +€7,275

    up €7,275 (+5.5%), from €131,769 to €139,043

    of which Other amounts receivable: +€5,380

  • Financial fixed assets +€5,431

    up €5,431 (+64.7%), from €8,389 to €13,820

Equity and liabilities
  • Trade debts -€23,757

    down €23,757 (-23.9%), from €99,418 to €75,662

  • Profit (loss) carried forward +€9,694

    up €9,694 (+6.8%), from €141,953 to €151,646

Income statement
  • Gross operating margin +€6,384

    up €6,384 (+9.7%), from €65,709 to €72,093

  • Financial charges +€3,403

    up €3,403 (+52.5%), from €6,479 to €9,882

  • Staff costs -€2,396

    down €2,396 (-6.8%), from €34,999 to €32,603

  • Depreciation +€744

    up €744 (+4.4%), from €16,745 to €17,488

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €6,171
Gross operating margin +€6,384
Staff costs +€2,396
Depreciation -€744
Other operating charges -€14
Financial income -€691
Financial charges -€3,403
Taxes -€405
Result 2025 €9,694
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€16,943
Investment -€5,431
Financing €0
Cash 2024 €28,282
Net result for the year +€9,694
Depreciation +€17,488
Stocks and contracts -€4,398
Receivables within one year -€7,275
Deferred charges and accrued income -€11,574
Trade debts -€23,757
Tax, wage and social debts +€485
Other debts +€2,391
Accrued charges and deferred income +€3
Investment in fixed assets (net) -€5,431
Cash 2025 €5,909
brings cash intakes cash out
Every line side by side 48 lines
Line Code 2024 2025 Change %
Total assets 20/58 €430,047 €418,862 -€11,185 -2.6%
Fixed assets 21/28 €65,760 €53,702 -€12,058 -18.3%
Tangible fixed assets 22/27 €57,370 €39,882 -€17,488 -30.5%
Plant, machinery and equipment 23 €47,765 €34,562 -€13,203 -27.6%
Furniture and vehicles 24 €8,514 €4,573 -€3,941 -46.3%
Other tangible fixed assets 26 €1,091 €747 -€345 -31.6%
Financial fixed assets 28 €8,389 €13,820 +€5,431 +64.7%
Current assets 29/58 €364,287 €365,160 +€873 +0.2%
Stocks and contracts in progress 3 €137,487 €141,885 +€4,398 +3.2%
Stocks 30/36 €137,487 €141,885 +€4,398 +3.2%
Amounts receivable within one year 40/41 €131,769 €139,043 +€7,275 +5.5%
Trade receivables 40 €4 €1,899 +€1,895 +47,131%
Other amounts receivable 41 €131,765 €137,145 +€5,380 +4.1%
Cash at bank and in hand 54/58 €28,282 €5,909 -€22,373 -79.1%
Deferred charges and accrued income 490/1 €66,749 €78,323 +€11,574 +17.3%
Total equity and liabilities 10/49 €430,047 €418,862 -€11,185 -2.6%
Equity 10/15 €209,793 €219,487 +€9,694 +4.6%
Contributions 10/11 €61,673 €61,673 = 0.0%
Capital 10 €61,673 €61,673 = 0.0%
Issued capital 100 €61,673 €61,673 = 0.0%
Reserves 13 €6,167 €6,167 = 0.0%
Non-distributable reserves 130/1 €6,167 €6,167 = 0.0%
Legal reserve 130 €6,167 €6,167 = 0.0%
Profit (loss) carried forward 14 €141,953 €151,646 +€9,694 +6.8%
Amounts payable 17/49 €220,254 €199,375 -€20,879 -9.5%
Amounts payable within one year 42/48 €220,246 €199,365 -€20,881 -9.5%
Financial debts 43 €100,000 €100,000 = 0.0%
Credit institutions 430/8 €100,000 €100,000 = 0.0%
Trade debts 44 €99,418 €75,662 -€23,757 -23.9%
Suppliers 440/4 €99,418 €75,662 -€23,757 -23.9%
Taxes, remuneration and social security 45 €8,145 €8,629 +€485 +5.9%
Taxes 450/3 €4,359 €4,729 +€371 +8.5%
Remuneration and social security 454/9 €3,786 €3,900 +€114 +3.0%
Other amounts payable 47/48 €12,684 €15,074 +€2,391 +18.8%
Accrued charges and deferred income 492/3 €7 €10 +€3 +37.8%
Remuneration, social security and pensions 62 €34,999 €32,603 -€2,396 -6.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €16,745 €17,488 +€744 +4.4%
Other operating charges 640/8 €505 €520 +€14 +2.8%
Gross operating margin 9900 €65,709 €72,093 +€6,384 +9.7%
Operating profit (loss) 9901 €13,461 €21,482 +€8,021 +59.6%
Financial income 75/76B €1,629 €938 -€691 -42.4%
Recurring financial income 75 €1,629 €938 -€691 -42.4%
Financial charges 65/66B €6,479 €9,882 +€3,403 +52.5%
Recurring financial charges 65 €6,479 €9,882 +€3,403 +52.5%
Profit (loss) for the period before taxes 9903 €8,610 €12,538 +€3,928 +45.6%
Income taxes 67/77 €2,439 €2,844 +€405 +16.6%
Profit (loss) for the period 9904 €6,171 €9,694 +€3,523 +57.1%
Profit (loss) for the period to be appropriated 9905 €6,171 €9,694 +€3,523 +57.1%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.